FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
cobas liat Bordetella panel nucleic acid test
K Number: K243753
·
Decision Nov 20, 2025
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
8
Applicant Total
51
Review Days
350
Basic Information
- Device Name
- cobas liat Bordetella panel nucleic acid test
- K Number
- K243753
- Device Class
- FDA class 2
- Clearance Type
- Dual Track
- Regulation Number
- 866.3980
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Roche Molecular Systems, Inc.
- Date Received
- December 5, 2024
- Decision Date
- November 20, 2025
- Product Code
- OZZ
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OZZ | Bordetella Pertussis Dna Assay System | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (OZZ), ordered by most recent decision date.
Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack
FDA 510(k)
FDA Class 2
·Microbiology
Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack
FDA 510(k)
FDA Class 2
·Microbiology
Solana Bordetella Complete Assay
FDA 510(k)
FDA Class 2
·Microbiology
ARIES Bordetella Assay; ARIES Bordetella Assay Protocol File Kit
FDA 510(k)
FDA Class 2
·Microbiology
Great Basin Bordetella Direct Test
FDA 510(k)
FDA Class 2
·Microbiology
illumigene Pertussis DNA Amplification Assay
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Roche Molecular Systems, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K253756 | cobas liat CT/NG nucleic acid test | May 15, 2026 | Substantially Equivalent |
| K253759 | cobas liat CT/NG/MG nucleic acid test | May 15, 2026 | Substantially Equivalent |
| K252484 | cobas HCV | Nov 3, 2025 | Substantially Equivalent |
| K252481 | cobas CMV | Nov 3, 2025 | Substantially Equivalent |
| K243455 | cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems | Jul 31, 2025 | Substantially Equivalent |
| K243863 | Opulus Lymphoma Precision | May 30, 2025 | Substantially Equivalent |
| K243400 | cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test | Apr 25, 2025 | Substantially Equivalent |
| K243406 | cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test | Apr 25, 2025 | Substantially Equivalent |
| K243346 | cobas liat SARS-CoV-2 v2 nucleic acid test | Apr 11, 2025 | Substantially Equivalent |
| K240867 | cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems | Feb 11, 2025 | Substantially Equivalent |